Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1993 1
1995 2
1996 1
1997 2
2006 2
2014 3
2015 2
2016 2
2017 4
2018 4
2019 3
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
Sandborn WJ, Feagan BG, Wolf DC, D'Haens G, Vermeire S, Hanauer SB, Ghosh S, Smith H, Cravets M, Frohna PA, Aranda R, Gujrathi S, Olson A; TOUCHSTONE Study Group. Sandborn WJ, et al. Among authors: frohna pa. N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248. N Engl J Med. 2016. PMID: 27144850 Free article. Clinical Trial.
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response.
De Gassart A, Le KS, Brune P, Agaugué S, Sims J, Goubard A, Castellano R, Joalland N, Scotet E, Collette Y, Valentin E, Ghigo C, Pasero C, Colazet M, Guillén J, Cano CE, Marabelle A, De Bonno J, Hoet R, Truneh A, Olive D, Frohna P. De Gassart A, et al. Among authors: frohna p. Sci Transl Med. 2021 Oct 20;13(616):eabj0835. doi: 10.1126/scitranslmed.abj0835. Epub 2021 Oct 20. Sci Transl Med. 2021. PMID: 34669444
Role of Vγ9vδ2 T lymphocytes in infectious diseases.
Gay L, Mezouar S, Cano C, Frohna P, Madakamutil L, Mège JL, Olive D. Gay L, et al. Among authors: frohna p. Front Immunol. 2022 Jul 18;13:928441. doi: 10.3389/fimmu.2022.928441. eCollection 2022. Front Immunol. 2022. PMID: 35924233 Free PMC article. Review.
Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials.
Verhoef C, Singla N, Moneta G, Muir W, Rijken A, Lockstadt H, de Wilt JHW, O-Yurvati A, Zuckerman LA, Frohna P, Porte RJ. Verhoef C, et al. Among authors: frohna p. J Surg Res. 2015 Apr;194(2):679-687. doi: 10.1016/j.jss.2014.12.011. Epub 2014 Dec 10. J Surg Res. 2015. PMID: 25586331 Clinical Trial.
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.
Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group. Hirano I, et al. Among authors: frohna p. Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2. Gastroenterology. 2019. PMID: 30395812 Free article. Clinical Trial.
Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.
Cohen JA, Comi G, Arnold DL, Bar-Or A, Selmaj KW, Steinman L, Havrdová EK, Cree BA, Montalbán X, Hartung HP, Huang V, Frohna P, Skolnick BE, Kappos L; RADIANCE Trial Investigators. Cohen JA, et al. Among authors: frohna p. Mult Scler. 2019 Aug;25(9):1255-1262. doi: 10.1177/1352458518789884. Epub 2018 Jul 25. Mult Scler. 2019. PMID: 30043658 Free PMC article. Clinical Trial.
25 results